INTECH Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Sell |
28,348
-7,476
| -21% | -$940K | 0.03% | 470 |
|
|
2025
Q1 | $3.96M | Sell |
35,824
-82,590
| -70% | -$9.13M | 0.04% | 405 |
|
|
2024
Q4 | $16.2M | Buy |
118,414
+15,819
| +15% | +$2.16M | 0.16% | 97 |
|
|
2024
Q3 | $11.8M | Buy |
102,595
+33,897
| +49% | +$3.91M | 0.13% | 144 |
|
|
2024
Q2 | $9.46M | Buy |
68,698
+44,512
| +184% | +$6.13M | 0.12% | 158 |
|
|
2024
Q1 | $3.34M | Buy |
24,186
+11,921
| +97% | +$1.64M | 0.05% | 289 |
|
|
2023
Q4 | $1.62M | Sell |
12,265
-5,328
| -30% | -$702K | 0.02% | 365 |
|
|
2023
Q3 | $1.98M | Sell |
17,593
-3,088
| -15% | -$347K | 0.03% | 351 |
|
|
2023
Q2 | $1.95M | Buy |
20,681
+16,398
| +383% | +$1.55M | 0.02% | 376 |
|
|
2023
Q1 | $434K | Sell |
4,283
-303
| -7% | -$30.7K | ﹤0.01% | 628 |
|
|
2022
Q4 | $548K | Buy |
4,586
+303
| +7% | +$36.2K | ﹤0.01% | 594 |
|
|
2022
Q3 | $455K | Buy |
4,283
+307
| +8% | +$32.6K | ﹤0.01% | 602 |
|
|
2022
Q2 | $388K | Buy |
+3,976
| New | +$388K | ﹤0.01% | 628 |
|